Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
3.72
Nov 13 • 3:59 PM ET Dollar change-0.14 Percentage change(-3.63%)
Aftermarket Close
3.67
Aftermarket • 7:51 PM ET Dollar change-0.05 Percentage change(-1.34%)
Category
US Equities - Factor & Thematic
Sponsor
Advisor Shares
Fund Family
Index
-
Index Weighting
Active/Passive
Expense
0.75%
Inverse/Leveraged
IPO
Sep 02, 2020
Asset Type
Equities (Stocks)
ETF Type
Bond Type
Average Maturity
Commodity Type
Quant Type
ESG Type
Dividend Type
Structure Type
Growth/Value
Market Cap
Option/Short
Yes / Yes
Tags
Tags
Tags
Tags
-
Tags
-
Tags
-
Tags
-
Sector/Theme
Region
SMA20
-8.40%
SMA50
-16.55%
SMA200
-15.93%
Return% 1Y
-13.89%
Return% 3Y
-15.61%
Return% 5Y
-33.29%
Return% 10Y
Return% SI
Flows% 1M
-4.84%
Flows% 3M
-11.81%
Flows% YTD
-9.79%
Flows% 1Y
Flows% 3Y
Flows% 5Y
Trades
Total Holdings
24
AUM
678.73M
NAV/sh
52W High
7.25 -48.69%
52W Low
2.96 25.68%
Volatility
4.83% 5.74%
ATR (14)
0.23
RSI (14)
36.50
Beta
1.54
Rel Volume
1.37
Avg Volume
5.04M
Volume
6,887,006
Perf Week
-12.26%
Perf Month
-9.71%
Perf Quarter
-18.06%
Perf Half Y
-15.65%
Perf YTD
-21.19%
Perf Year
-7.00%
Perf 3Y
-45.29%
Perf 5Y
-88.40%
Perf 10Y
-
Prev Close
3.86
Price
3.72
Change %
-3.63%
AdvisorShares Pure US Cannabis ETF seeks long-term capital appreciation. The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology & life sciences industry group within the health care sector. The fund is non-diversified.